Skip to main content
Premium Trial:

Request an Annual Quote

ABI Restructures Its Marketing, Distribution Pact With Celera

NEW YORK, Feb. 10 (GenomeWeb News) - Applera's board has said Applied Biosystems and Celera Genomics can restructure their 10-year marketing and distribution agreement.

 

Specifically, the arrangement allows ABI to exclusively integrate Celera Discovery System data and other genomic and biological information into its product offerings, including TaqMan assays, SNPlex Genotyping Systems, and Expression Array System, in return for royalties based on revenues generated by sales of some products.

 

Disclosed in an SEC filing this week, the amended agreement increases the royalty rate to 4 percent from 3 percent. The deal also extends the agreement by five years, which means it will now run through the end of the company's FY 2017.

The Scan

Genome Sequences Reveal Range Mutations in Induced Pluripotent Stem Cells

Researchers in Nature Genetics detect somatic mutation variation across iPSCs generated from blood or skin fibroblast cell sources, along with selection for BCOR gene mutations.

Researchers Reprogram Plant Roots With Synthetic Genetic Circuit Strategy

Root gene expression was altered with the help of genetic circuits built around a series of synthetic transcriptional regulators in the Nicotiana benthamiana plant in a Science paper.

Infectious Disease Tracking Study Compares Genome Sequencing Approaches

Researchers in BMC Genomics see advantages for capture-based Illumina sequencing and amplicon-based sequencing on the Nanopore instrument, depending on the situation or samples available.

LINE-1 Linked to Premature Aging Conditions

Researchers report in Science Translational Medicine that the accumulation of LINE-1 RNA contributes to premature aging conditions and that symptoms can be improved by targeting them.